Compare Expensify Inc (EXFY) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expensify Inc vs Oscar Health Inc — how do they compare? Expensify Inc trades at $2.4 (market cap $208.82M), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is far larger — about 48.9× Expensify Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, Expensify Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Expensify Inc for 41 Days and Oscar Health Inc for 15 Days on average.
| EXFY | OSCR | |
|---|---|---|
Market Cap | $208.82M | $10.22B |
Volume | 456,102 | 4,123,394 |
Sector | Technology | Health |
52-Week High | $2.72 | $33.81 |
52-Week Low | $0.75 | $10.85 |
Typical Hold Time | 41 Days | 15 Days |
Enterprise Value | $148.44M | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expensify (EXFY) trades at $2.40, up 5.73% today, showing technical bullish momentum. The company reported mixed quarterly results with recent beats but remains unprofitable with negative margins. Recent business developments include strategic AI integrations and European expansion of its corporate card program, signaling growth initiatives. Analyst sentiment is cautiously optimistic with a 50% buy rating and $13.75 consensus target, though fundamentals show continued losses.
The outlook remains speculative given persistent negative profitability despite revenue stabilization. Investment opportunity hinges on successful execution of AI integrations and international expansion driving future profitability. Key risks include competitive pressure in expense management software and the challenge of achieving sustainable positive earnings amid ongoing operational losses.
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
